Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MLS for Glucose Testing Aids POC Diagnostics in UK

By LabMedica International staff writers
Posted on 18 Aug 2009
A managed laboratory service (MLS) for point of care (POC) diagnostics will improve blood glucose testing services in Liverpool hospitals (UK).

The MLS covers 185 wireless-enabled Accu-Chek Inform II blood glucose meters, which will be located in four hospitals at three sites in Liverpool. More...
Connectivity to the laboratory information system (LIMS)--and ultimately to the hospital information systems--will be achieved via wireless connection, using the cobas IT1000 dedicated data management system. Information is to be transferred bidirectionally and automatically, allowing real-time availability of test results and a full audit trail.

Before the adoption of the MLS service, handheld glucose meters have been used. Kath Ashton, POC testing manager for the blood sciences department for the Liverpool National Health Service (NHS) Trust (UK), will be responsible for handling the new blood glucose testing service. She explained why the current system is problematic, "Performing nearly half a million tests every year, monitoring internal quality control, and external quality assessment of glucose testing was extremely labor intensive, involving bimonthly audits on each instrument."

This will be one of the first POC managed laboratory service agreements in the U.K. Roche UK (Welwyn Garden City, UK) will provide the new service, which will help the Trusts meet new and on-going Clinical Pathology Accreditation (CPA) requirements for POC glucose testing.

Related Links:
Liverpool National Health Service Trust
Roche UK


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.